John B. Penney

Active 1973–2006

82
Papers
24,132
Citations
79
h-index
82
i10-index

Citations

Citations per year for John B. Penney1963: 1 citations1975: 3 citations1976: 2 citations1977: 1 citations1978: 2 citations1980: 1 citations1981: 2 citations1982: 5 citations1983: 12 citations1984: 17 citations1985: 16 citations1986: 41 citations1987: 84 citations1988: 108 citations1989: 110 citations1990: 173 citations1991: 141 citations1992: 151 citations1993: 122 citations1994: 168 citations1995: 205 citations1996: 213 citations1997: 227 citations1998: 211 citations1999: 272 citations2000: 362 citations2001: 309 citations2002: 254 citations2003: 259 citations2004: 284 citations2005: 228 citations2006: 246 citations2007: 186 citations2008: 213 citations2009: 195 citations2010: 227 citations2011: 234 citations2012: 186 citations2013: 146 citations2014: 194 citations2015: 131 citations2016: 125 citations2017: 94 citations2018: 113 citations2019: 312 citations2020: 276 citations2021: 284 citations2022: 204 citations2023: 123 citations2024: 230 citations2025: 91 citations2026: 4 citations1964–1974: no citations, so these years are not shown1979: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,119 citing papers, 39% of this breakdownUnited Kingdom: 716 citing papers, 9% of this breakdownGermany: 448 citing papers, 5.6% of this breakdownCanada: 438 citing papers, 5.5% of this breakdownFrance: 380 citing papers, 4.7% of this breakdownItaly: 341 citing papers, 4.3% of this breakdownJapan: 269 citing papers, 3.4% of this breakdownSpain: 246 citing papers, 3.1% of this breakdownChina: 192 citing papers, 2.4% of this breakdownAustralia: 187 citing papers, 2.3% of this breakdownSweden: 167 citing papers, 2.1% of this breakdownNetherlands: 149 citing papers, 1.9% of this breakdown
0%39%Other 16.7%

Fields

  • Neuroscience56.9%
  • Medicine30.3%
  • Biochemistry, Genetics and Molecular Biology9.5%
  • Psychology1.5%
  • Engineering0.3%
  • Health Professions0.2%
  • Other1.3%

Topics

  • Neurological disorders and treatments11.7%
  • Genetic Neurodegenerative Diseases11.4%
  • Neuroscience and Neuropharmacology Research11.2%
  • Parkinson's Disease Mechanisms and Treatments7.1%
  • Mitochondrial Function and Pathology5.4%
  • Neurotransmitter Receptor Influence on Behavior4.3%
  • Other48.9%

Coauthors

All papers

Open in search
  1. The functional anatomy of basal ganglia disorders

    Authors: , , - Trends in Neurosciences 1989 cited by 5,362

  2. Trinucleotide repeat length instability and age of onset in Huntington's disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , S. Robert Snodgrass, Margot de Young, Nancy S. Wexler, Chaya Moscowitz, Graciela K. Penchaszadeh, H MacFarlane, Mark J. Anderson, Bruce G. Jenkins, Jayalakshmi Srinidhi, Glenn Barnes, James F. Gusella, Marcy E. MacDonald - Nature Genetics 1993 cited by 1,099

  3. Differential loss of striatal projection neurons in Huntington disease.

    Authors: , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1988 cited by 1,012

  4. CAG repeat number governs the development rate of pathology in Huntington's disease

    Authors: , , , , - Annals of Neurology 1997 cited by 676

  5. Anatomical and affinity state comparisons between dopamine D1 and D2 receptors in the rat central nervous system

    Authors: , , - Neuroscience 1989 cited by 454

  6. Rate of functional decline in Huntington’s disease

    Authors: , , , , , , , , , , , - Neurology 2000 cited by 358

  7. The functional anatomy of disorders of the basal ganglia

    Authors: , , - Trends in Neurosciences 1995 cited by 367

  8. Huntingtin localization in brains of normal and Huntington's disease patients

    Authors: , , , , , , , , - Annals of Neurology 1997 cited by 353

  9. Differential loss of striatal projection systems in Huntington’s disease: a quantitative immunohistochemical study

    Authors: , , , , , - Journal of Chemical Neuroanatomy 2004 cited by 213

  10. Preferential loss of striato‐external pallidal projection neurons in presymptomatic Huntington's disease

    Authors: , , , , , , , , - Annals of Neurology 1992 cited by 368

  11. Homozygotes for Huntington's disease

    Authors: , , , , , , , , , , , , , , , , , , - Nature 1987 cited by 352

  12. Glutamate transmission and toxicity in alzheimer's disease

    Authors: , , , , - Progress in Neuro-Psychopharmacology and Biological Psychiatry 1988 cited by 197

  13. Expression of Normal and Mutant Huntingtin in the Developing Brain

    Authors: , , , , , , , , , , - Journal of Neuroscience 1996 cited by 196

  14. NMDA Receptor Losses in Putamen from Patients with Huntington's Disease

    Authors: , , , , , , - Science 1988 cited by 394

  15. Glutamate dysfunction in Alzheimer's disease: an hypothesis

    Authors: , , , - Trends in Neurosciences 1987 cited by 336

  16. Abnormalities of Striatal Projection Neurons andN-Methyl-D-Aspartate Receptors in Presymptomatic Huntington's Disease

    Authors: , , , , , , , , - New England Journal of Medicine 1990 cited by 245

  17. Altered neurotransmitter receptor expression in transgenic mouse models of Huntington's disease

    Authors: , , , , , , , , , - Philosophical Transactions of the Royal Society B Biological Sciences 1999 cited by 240

  18. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride Neurotoxicity Is Attenuated in Mice Overexpressing Bcl-2

    Authors: , , , , , , , , - Journal of Neuroscience 1998 cited by 199

  19. Gametic but not somatic instability of CAG repeat length in Huntington's disease.

    Authors: , , , , , , , , , - Journal of Medical Genetics 1993 cited by 191

  20. CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain

    Authors: , , , , , , , , , , , , , , , , - Neuron 1995 cited by 184

  21. Positron emission tomographic scan investigations of Huntington's disease: Cerebral metabolic correlates of cognitive function

    Authors: , , , , , , , , - Annals of Neurology 1988 cited by 170

  22. Localization of metabotropic glutamate receptor 7 mRNA and mGluR7a protein in the rat basal ganglia

    Authors: , , , , , , , - The Journal of Comparative Neurology 1999 cited by 156

  23. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease

    Authors: , , , , , , , , , , , , , , - Nature 1999 cited by 646

  24. Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human Huntington disease gene

    Authors: , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 1998 cited by 504